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Abstract 
 
Objective: To investigate the correlation of the vestibular evoked myogenic 
potential (VEMP) score with Timed 25-Foot Walk (T25FW), 9-Hole Peg Test 
(9HPT), Paced Auditory Serial Addition Test (PASAT) and EDSS in patients with 
multiple sclerosis (MS). 
Methods: This prospective, cross sectional study included 52 patients with 
clinically isolated syndrome (CIS). Cervical VEMP (cVEMP) and ocular VEMP 
(oVEMP), analyzed in the form of the cVEMP, oVEMP and VEMP scores, T25FW, 
9HPT, PASAT and Expanded Disability Status Scale (EDSS) were performed. 
Results: The only predictor of walking impairment in this study was general 
disability as measured by the EDSS, after controlling for age, gender, PASAT and 
EDSS the effect of VEMP score was non-significant (p=0.419). 9HPT of the 
dominant hand did not correlate with the oVEMP score (rs=0.258, p=0.065), 
however after controlling for age, gender, PASAT and EDSS, the effect of the 
oVEMP score on 9HPT of the dominant hand was statistically significant 
(p=0.017). After controlling for age, gender and oVEMP score, the effect of the 
PASAT on 9HPT variable for the non-dominant hand was statistically significant 
(p=0.001). 
Conclusion: We found possible effects of brainstem dysfunction on walking 
impairment, however they were not seen after correction for EDSS and cognitive 
dysfunction. On the other hand, dominant hand function seems to be influenced 
by upper brainstem dysfunction measured with oVEMP, while cognitive 
dysfunction is related to non-dominant hand function. 
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Highligts 
 
 The only predictor of walking impairment was general disability measured 
by the EDSS. 
 We found positive correlation of the oVEMP score and 9HPT of the dominant 
hand. 
 In brainstem/cerebellar type of CIS, MSFC strongly correlated with cVEMP. 
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1. Introduction 
Predicting disease progression is critical for patients with multiple sclerosis 
(MS), especially in the initial phase of the disease. This initial phase is in about 
85% of patients a relapse, which is known as a clinically isolated syndrome (CIS). 
Several clinical, MRI and neurophysiological parameters have been used to 
assess disability and try to predict development of future disability in MS 
patients. The Expanded Disability Status Scale (EDSS) has long been considered 
the gold standard for measurement of disability and disease progression in MS. 
(1) However, the EDSS has several limitations, including the need for a 
neurologist to examine the patient and derive the score; at the lower end of the 
scale the EDSS becomes imprecise because of the subjectivity in determining the 
scores; in the middle and upper regions of the scale, the EDSS is weighted heavily 
toward ambulatory disability and is less sensitive to other dimensions of MS 
such as arm and cognitive function; and nonlinearity of the scale (2). In the last 
two decades, the Multiple Sclerosis Functional Composite (MSFC), a 3-part 
quantitative instrument that measures arm, leg, and cognitive function with the 
9-Hole Peg Test (9HPT), the Timed 25-Foot Walk (T25FW), and the Paced 
Auditory Serial Addition Test (PASAT), respectively, was introduced to 
supplement the EDSS. (3) The MSFC has excellent test-retest reliability, has the 
power to differentiate patients with primary or secondary progressive MS 
compared with relapsing-remitting MS (RRMS), and significantly correlates with 
the EDSS, the Sickness Impact Profile, and the Short Form-36 (patient-reported 
survey of patient health) and MRI changes. (2) More importantly, it has been 
shown that baseline MSFC scores in patients with RRMS were predictive of brain 
atrophy 2 and 8 years later. (4,5)  
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On the other hand, several evoked potentials (EP) have been successfully used in 
the determination of functional impairment in MS patients: somatosensory EP 
(SSEP), motor EP (MEP), visual EP (VEP) and brainstem EP (BAEP). More 
importantly, several studies have shown that the total number of pathological 
EPs better correlates with EDSS compared to MRI and can predict future 
disability of MS patients.(6,7) The main problem with the EP score is that the 
brainstem is underrepresented in the overal score, since none of these EPs 
demonstrate good correlation with brainstem involvement. On the other hand, 
the p14 component of medial nerve SSEP correlates with the brainstem 
involvement (8), however there are no direct comparisons between VEMPs and 
SSEPs. Furthermore, p14 component of the SSEP was not analyzed in the original 
EP score calculation (7). 
Our group has recently developed the vestibular evoked myogenic potentials 
(VEMP) score with the aim to explore its potential to replace the BAEP in the EP 
score. The VEMP score is the sum of four 4-graded scores derived from the 
evaluation of 2 ocular VEMPs (oVEMP) and 2 cervical VEMPs (cVEMP). oVEMP 
evaluates the upper part of the brainstem (midbrain and upper pons), while 
cVEMP evaluates the lower part of the brainstem (lower pons and medulla 
oblongata), as well as upper parts of the cervical spinal cord. We found that the 
VEMP score correlates well with disability and disease duration and enables 
better evaluation of brainstem dysfunction than the MRI in patients with RRMS. 
(9)  
Therefore, the aim of this study was to investigate the correlation of the VEMP 
score with walking in the form of T25FW, hand function in the form of 9HPT, and 
overall disability in the form of EDSS and MSFC. 
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2. Methods 
2.1. Design 
This was a prospective, cross sectional study which included consecutive 
patients who were diagnosed with a first clinical symptom of multiple sclerosis 
(CIS) from the 1st of August 2014 until 1st of May 2015 at the Department of 
Neurology, University Hospital Center Zagreb - a tertiary medical center and a 
referral center for multiple sclerosis. Diagnosis of CIS was made with the 
following criteria: 1) acute or subacute development of neurological symptoms 
and/or signs lasting longer than 48 hours in the absence of fever or infection, 2) 
brain and spinal cord MRI showing at least 2 demyelinating lesions larger than 3 
mm or 1 lesion larger than 3 mm that corresponded to the symptom and/or sign. 
Based on the clinical presentation, patients were classified into 5 CIS subtypes: 
optic neuritis (ON), incomplete transverse myelitis (TM), brainstem/cerebellar 
(BC), hemispheral (H) and multifocal (M). 
 
The Ethical committees of the University Hospital Center Zagreb and University 
of Zagreb, School of Medicine approved the study. All participants gave written 
informed consent. 
 
2.2. Vestibular evoked myogenic potentials  
Methods of recordings and analysis of recorded data were designed according to 
previously described details. (10,11) 
The stimuli were delivered via a pair of headphones in series of 50 trials to one 
ear at a time and repeated two times for each ear in order to provide 
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reproducibility. The stimuli used were acoustic clicks of 1ms duration at an 
intensity of 130dB (pSPL) and a stimulation frequency of 1Hz. The recordings 
were performed using a Brain Products Brain Vision Recorder (Brain Products 
GmbH Munich, Germany) and the analysis of the recorded data was performed 
using a Brain Products Brain Vision Analyzer (Brain Products GmbH Munich, 
Germany). Signals were filtered with a bandpass filter from 0.5 Hz to 1000 Hz. 
For the purpose of the analysis, signals were divided in segments of 120 ms 
duration (20 ms before the stimulus appearance and 100 ms after the stimulus 
appearance) and averaged for each set of 50 trials. A grand average was 
computed and used for further analysis from the averaged responses of the two 
sets. 
The following VEMP components were analyzed: peak-to-peak n10-p13 
amplitude, n10 and p13 latencies for oVEMP, and normalized p13-n23 
amplitude, p13 and n23 latencies for cVEMP. We used baseline normalized 
values of the SCM amplitude data instead of the absolute value of the amplitude, 
because absolute amplitude of the evoked response depends on the amplitude of 
the muscle activity (muscle contraction) and is not a reliable measure. The 
baseline normalized value of amplitude is calculated by dividing the absolute 
peak to peak amplitude (p13-n23) with mean value of rectified activity of muscle 
in the period prior the stimulus. For the ocular muscles (OM) amplitudes we 
used absolute values. Due to the variability of evoked potentials, SCM amplitudes 
were considered abnormal if the amplitude was decreased for > 1.0 standard 
deviation compared to the mean value of the laboratory or when it was 
decreased for > 50% compared to the contralateral response. OM amplitudes 
were considered abnormal if the amplitude was < 50% of the mean value of the 
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laboratory or when it was decreased for > 50% compared to the contralateral 
response. These amplitude criteria are more lenient than those typically used to 
detect vestibular abnormalities in other laboratories. They provide increased 
sensitivity to subtle VEMP abnormalities, but may include false positives. 
Similarly, latencies were considered prolonged when there was an increase in > 
2.5 standard deviations to the mean value of the laboratory. Absent responses 
(presumed conduction blocks) were also considered as abnormal findings.  
All VEMP results were interpreted according to the VEMP score. (9) The VEMP 
score is the sum of four 4-graded scores derived from the evaluation of each 
VEMP. The 4 grades are: 0 = normal, 1 = increased latency with normal 
amplitude and morphology of major potentials, 2 = decrease in amplitude or 
altered morphology of major potentials, 3 = absence of a major potential. 
Minimal and maximal values of the oVEMP score and cVEMP score are 0 and 6, 
and the VEMP score 0 and 12, respectively. 
 
2.3. Clinical assessment 
Participants completed all testing in a single session, which included the 
following: Expanded Disability Status Scale (EDSS), followed by the MSFC, which 
was administered to patients using a standardized protocol. (3) The order of 
testing in a session was as follows: (1) T25FW (trial 1 and trial 2), (2) 9HPT 
(dominant hand: trial 1 and trial 2; and nondominant hand: trial 1 and trial 2), 
and (3) PASAT (3-second interstimulus interval). T25FW and 9HPT results were 
analyzed as absolute values when they were used separately, and in the form of 
the z score for MSFC analysis.  
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2.4. Outcomes 
 
Outcomes of the study were to determine whether the VEMP score correlates 
with walking impairment measured with T25FW and with upper limb function 
measured with 9HPT in patients with CIS. Furthermore we wanted to determine 
the impact of cognitive function measured with PASAT on T25FW and 9HPT; 
whether the VEMP score correlates with the EDSS, brainstem functional score of 
the EDSS (BSFS) and MSFC; and if there is a difference in T25FW, 9HPT and 
MSFC between the three major CIS subtypes: ON, BC and TM. 
 
 
2.5. Statistical analysis 
 
Statistical analysis was performed using the IBM SPSS software, version 20. The 
Kolmogorov-Smirnov test was applied to test whether the data had a normal 
distribution. Differences in quantitative variables were determined with the use 
of the Mann Whitney U test. Correlations for parametric variables were performed by 
Pearson, and for nonparametric variables by Spearman correlation. We used a linear 
regression method in order to examine the influence of predictors of interest on 
specific outcome.  P values less than 0.05 were considered significant.  
When interpreting the strength of correlation, we used the following 
categorization: 0.1-0.3 modest, 0.3-0.5 moderate, 0.5-0.8 strong, 0.8-0.9 very 
strong and 1 perfect. 
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3. Results 
 
3.1. Patients 
 
We included 52 patients with CIS (40 were female), mean age of 32.79 ± 10.15 
years, with the median EDSS of 1.0 (0-3.5) and median BSFS of 0 (0-3). There 
were 17 patients with ON, 18 with BC, 12 with TM, 4 hemispheral and 1 
multifocal type of CIS. Table 1 summarizes the mean values of EDSS, BSFS, and 
VEMP scores results with respect to the specific types of CIS. 
Regarding the cVEMP, 26 patients had normal cVEMP amplitudes, 20 had small 
cVEMP amplitudes and 6 patients had absent cVEMP response. Regarding the 
oVEMP, 16 patients had normal oVEMP amplitudes, 25 had small oVEMP 
amplitudes and 11 patients had absent oVEMP response. 
 
3.2. Ambulation/walking 
 
In the whole group, oVEMP score correlated with the T25FW (rs=0.280, 
p=0.045). The VEMP score did not correlate with T25FW (rs=0.248, p=0.076). 
There was no correlation between VEMPs and T25FW for each individual CIS 
subtypes (Table 2). As well, there was no difference in the oVEMP, cVEMP and 
VEMP scores between patients with BC type of CIS and all other patients 
(p=0.223, p=0.417, p=0.846, respectively). 
In order to evaluate the relationship between cognitive dysfunction and walking 
impairment, we correlated PASAT with T25FW, and found a significant 
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correlation (Pearson correlation=-0.281, p=0.043), indicating that a lower 
performance on the PASAT test is related to worse performance on the T25FW.  
Results of linear regression analysis with T25FW as an outcome are presented in 
supplementary table 1. After controlling for age and gender, the effect of the 
PASAT on T25FW was reduced and non-significant. There was also a non-
significant effect of VEMP score on T25FW. Also, after controlling for age and 
gender, the effect of the oVEMP score on T25FW was reduced and non-
significant, as presented in supplementary table 2.  The only significant predictor 
for T25FW was EDSS, when controlling for age and gender.  
  
3.3. Upper extremity function 
 
There was no correlation of the 9HPT of the dominant hand and the oVEMP 
score, cVEMP score or VEMP score (Table 3). However, when we analyzed 
correlations for each subtype of CIS (ON, BC and TM) we found a positive 
correlation between 9HPT of the dominant hand and oVEMP score for BC 
subtype (rs=0.581, p=0,011). Regarding the 9HPT of the non-dominant hand, we 
found no correlations with the oVEMP, cVEMP and VEMP scores (Table 3).  
In order to evaluate the relationship between cognitive dysfunction and upper 
extremity function, we correlated PASAT with 9HPT and found a significant 
correlation (Pearson correlation=-0.490, p<0.0001) with 9HPT of the non-
dominant hand, indicating that a lower performance on the PASAT score is 
related to worse performance on the 9HPT. There was no correlation between 
PASAT and 9HPT of the dominant hand (Pearson correlation=-0.204, p=0.146). 
 13 
Results of linear regression analysis with 9HPT for the dominant hand as an 
outcome are presented in supplementary table 3. After controlling for age and 
gender, the effect of the PASAT on 9HPT was not statistically significant. After 
controlling for age, gender and PASAT, the effect of the oVEMP score on 9HPT 
was statistically significant, as was the effect of the EDSS. Results of linear 
regression analysis with 9HPT for the non-dominant hand as an outcome are 
presented in supplementary table 3. After controlling for age and gender, the 
effect of the PASAT on 9HPT was statistically significant. After controlling for 
age, gender and oVEMP score, the effect of the PASAT on 9HPT for the non-
dominant hand was statistically significant. The effect of the EDSS was also 
statistically significant. The effect of the oVEMP score was not statistically 
significant for the non-dominant hand. 
 
 
3.4. Multiple sclerosis functional composite 
 
For the whole group, MSFC did not correlate with any of the VEMP score 
variables (Table 4). However, in the BC subgroup, MSFC significantly correlated 
with the cVEMP score (rs=0.547, p=0,019). 
Finally, the VEMP score did not correlate with the EDSS or BSFS (rs=0.023, 
p=0,869 and rs=0.219, p=0,118, respectively); however, the oVEMP score 
correlated with the BSFS (rs=0.308, p=0,026). EDSS did not correlate with the 
MSFC (rs=0.051, p=0,722); however, it did correlate with T25FW and 9HPT of 
the dominant hand (rs=0.353, p=0,010 and rs=0.364, p=0,008, respectively).  
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4. Discussion 
 
The first finding of this study is that any significant relationship between VEMPs 
and T25FW was mediated by age and/or gender. The only measure that was 
independently correlated with T25FW after controlling for all other factors was 
the EDSS.  
Several studies have tried to address the pathophysiological aspects of walking 
impairment in MS, mainly focusing on impaired motor control and/or sensation 
in lower extremities. (12, 13,14) Furthermore, several MRI studies tried to 
correlate MRI burden of the disease with walking impairment. (15,16) However, 
as the information provided by evoked potentials is more related to function 
unlike the information provided by MRI, which is more related to anatomy, 
evoked potentials may prove to be more useful in monitoring disease evolution 
in MS (17). For some neurophysiological methods, like the blink reflex, it has 
even been shown a good correlation between the pathological response and 
brainstem disease burden. (18) Despite of this, only one study investigated the 
correlation between T25FW and different evoked potentials (motor and 
somatosensory evoked potentials) (19). That study has shown that both motor 
and somatosensory evoked potentials and their combination correlate well with 
T25FW, indicating that evoked potentials might be useful in the clinical follow up 
of MS patients. Our study showed that the same is not true for VEMPs, which did 
not independently predict walking impairment. 
Although most of the attention has been focused on lower limb impairments, 
cognition is another factor that should be taken into account when evaluating 
walking impairment in MS. It has been shown that processing speed and 
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executive function tests were significant predictors of lower and upper motor 
function in MS; where cognitive tests predicted variability in motor function 
after controlling for disease duration and physical disability. (20) We found a 
modest correlation between PASAT and T25FW, however, this effect was 
reduced to non-significant after controlling for age and EDSS.  
The possible explanation for non-significant correlation of both VEMP and 
PASAT on T25FW after adjusting for age and EDSS, could be partly explained by 
the fact that only patients with early MS and thus very mild disability were 
included. Further research should focus on combining MRI and evoked 
potentials in the evaluation of the brainstem and its influence on walking, to 
further explore this possible association. 
 
The second finding of this study was the strong positive correlation between 
9HPT of the dominant hand and oVEMP score for CIS patients with 
brainstem/cerebellar symptomatology. Furthermore, linear regression analysis 
on the whole group showed that after controlling for age, gender and PASAT 
score, the effect of the oVEMP score on 9HPT of the dominant hand was 
statistically significant. Unlike the walking impairment, only few studies 
evaluated upper extremity impairment in MS. (21) It has been shown that a 
significantly longer time to complete the 9-HPT is needed in patients with 
abnormal somatosensory evoked potentials of the median nerve. (22) More 
precisely, patients with undetectable P14 responses (which represent a 
brainstem response) performed the 9-HPT in a significantly longer time than 
patients with detectable P14 responses, indicating that the brainstem is 
responsible for upper extremity dysfunction. These findings are in line with the 
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present study as well, showing the correlation between oVEMPs and 9HPT of the 
dominant hand. In contrast, there was no correlation between non-dominant 
hand function and brainstem function measured with VEMPs. However, we 
found a strong correlation between cognitive function measured with PASAT and 
non-dominant hand function measured with 9HPT. This discrepancy between 
dominant and non-dominant hand function in MS has been described previously 
with functional MRI studies. Firstly, it has been shown that movement-associated 
cortical activation in patients with progressive MS is widely distributed and also 
involves multimodal "nonmotor" cortical networks. (23) Secondly, it has been 
shown that increased cognitive effort is required for performing non-dominant 
hand movements. (24) Moreover, a recent fMRI study by Rico et al. examined 
bilateral movements in CIS patients with low disability and devoid of 
corticospinal dysfunction found activation of different brain areas when patients 
performed non-dominant hand movements compared to dominant hand 
movements. (25) These findings suggest that non-dominant hand movements 
result in recruitment of brain networks involved in cognitive control in MS 
patients with minimal or no disability. Taking all of this into account and with 
the results of the present study it seems that there is a difference between 
dominant and non-dominant hand function in MS.  
The third finding of this study is significant correlation of the MSFC with the 
cVEMP score in the BC subgroup of CIS patients. This finding is interesting given 
the fact that spinal cord cross-sectional area correlates significantly with the 
MSFC score, and cVEMP measures vestibulospinal pathways up to the C4 level. 
(26) 
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The limitations of this study are the relatively small number of participants and 
the fact that only CIS patients with very mild disability were included. This could 
explain the negative results of the linear regression analysis on the VEMP 
influence on T25FW.  
In conclusion, the only predictor of walking impairment in this study was general 
disability as measured by the EDSS. On the other hand, dominant hand function 
seems to be influenced by upper brainstem dysfunction, while cognitive 
dysfunction is related to non-dominant hand function. Further studies including 
a combination of different MRI measures and combination of different evoked 
potentials are warranted.  
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Tables 
 
 
Table 1. Mean values (range) of EDSS, BSFS, and all the VEMP scores with 
regards to type of CIS. ON - optic neuritis, TM - incomplete transverse myelitis, 
BC – brainstem or cerebellar type of CIS. 
 
 ON TM BC 
N 17 12 18 
EDSS 1.0 (0-2.5/10) 1.0 (0-3.0/10) 2.0 (0-3.5/10) 
BSFS 0 (0-2/5) 0 (0-2/5) 1.5 (0-3/5) 
VEMP score 4 (0-12/12) 5.5 (0-10/12) 4 (0-9/12) 
oVEMP score 3 (0-6/6) 3 (0-6/6) 4 (0-6/6) 
cVEMP score 1 (0-6/6) 2.5 (0-5/6) 1 (0-4/6) 
 
 
Table 2. Correlations of the VEMP scores and T25FW in the whole cohort and 
different CIS subtypes. ON - optic neuritis, TM - incomplete transverse myelitis, 
BC – brainstem or cerebellar type of CIS, /XX indicates the maximum score 
possible. 
 
  oVEMP score cVEMP score VEMP score 
CIS 
T25FW rs 0.280 0.159 0.248 
p value 0.045* 0.262 0.076 
ON 
T25FW rs 0.285 0.202 0.255 
p value 0.267 0.437 0.323 
TM 
T25FW rs 0.348 -0.096 0.118 
p value 0.267 0.766 0.715 
BC 
T25FW rs 0.324 0.256 0.434 
p value 0.190 0.305 0.072 
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Table 3. Correlations of the VEMP scores and 9HPT for dominant and non-
dominant hand in the whole cohort and different CIS subtypes. ON - optic 
neuritis, TM - incomplete transverse myelitis, BC – brainstem or cerebellar type 
of CIS. 
 
  oVEMP 
score 
cVEMP 
score 
VEMP 
score 
oVEMP 
score 
cVEMP 
score 
VEMP 
score 
  dominant hand non-dominant hand 
CIS 
9HPT rs 0.258 -0.081 0.154 -0.018 0.027 0.024 
p  0.065 0.568 0.277 0.901 0.849 0.864 
ON 
9HPT rs 0.429 -0.021 0.278 -0.095 -0.248 -0.121 
p  0.086 0.937 0.279 0.716 0.338 0.643 
TM 
9HPT rs -0.181 -0.210 -0.324 0.131 -0.149 -0.075 
p  0.574 0.512 0.303 0.685 0.645 0.817 
BC 
9HPT rs 0.581 -0.391 0.295 -0.067 0.273 0.170 
p  0.011* 0.109 0.235 0.792 0.273 0.501 
 
 
 
Table 4. Correlations of the VEMP scores and MSFC in the whole cohort and 
different CIS subtypes. ON - optic neuritis, TM - incomplete transverse myelitis, 
BC – brainstem or cerebellar type of CIS. 
 
  oVEMP score cVEMP score VEMP score 
CIS 
MSFC rs 0.008 0.143 0.083 
p value 0.957 0.113 0.559 
ON 
MSFC rs -0.060 0.287 0.067 
p value 0.820 0.265 0.799 
TM 
MSFC rs 0.014 -0.040 -0.011 
p value 0.965 0.902 0.974 
BC 
MSFC rs -0.010 0.547 0.346 
p value 0.970 0.019* 0.159 
 
